nodes	percent_of_prediction	percent_of_DWPC	metapath
Ofloxacin—SLC22A4—rheumatoid arthritis	0.503	1	CbGaD
Ofloxacin—ABCC1—Cyclosporine—rheumatoid arthritis	0.0537	0.18	CbGbCtD
Ofloxacin—ABCC2—Sulfasalazine—rheumatoid arthritis	0.0524	0.176	CbGbCtD
Ofloxacin—ABCC2—Cyclosporine—rheumatoid arthritis	0.0397	0.134	CbGbCtD
Ofloxacin—CYP1A2—Leflunomide—rheumatoid arthritis	0.0316	0.106	CbGbCtD
Ofloxacin—SLC22A6—Cyclosporine—rheumatoid arthritis	0.0291	0.0977	CbGbCtD
Ofloxacin—ABCC1—Methotrexate—rheumatoid arthritis	0.0284	0.0955	CbGbCtD
Ofloxacin—ABCC2—Dexamethasone—rheumatoid arthritis	0.0262	0.0879	CbGbCtD
Ofloxacin—ABCC2—Methotrexate—rheumatoid arthritis	0.021	0.0707	CbGbCtD
Ofloxacin—SLC22A6—Methotrexate—rheumatoid arthritis	0.0154	0.0517	CbGbCtD
Ofloxacin—Levofloxacin—SLC22A4—rheumatoid arthritis	0.000815	0.688	CrCbGaD
Ofloxacin—SLC22A5—Organic cation transport—SLC22A4—rheumatoid arthritis	0.000538	0.139	CbGpPWpGaD
Ofloxacin—Gatifloxacin—ALB—rheumatoid arthritis	0.00037	0.312	CrCbGaD
Ofloxacin—SLC22A5—Organic cation/anion/zwitterion transport—SLC22A4—rheumatoid arthritis	0.000365	0.0939	CbGpPWpGaD
Ofloxacin—TOP2A—Methyltestosterone—Hydrocortisone—rheumatoid arthritis	0.000303	0.258	CbGdCrCtD
Ofloxacin—SLC22A6—Organic cation/anion/zwitterion transport—SLC22A4—rheumatoid arthritis	0.000276	0.0709	CbGpPWpGaD
Ofloxacin—TOP2A—Methyltestosterone—Prednisone—rheumatoid arthritis	0.000261	0.222	CbGdCrCtD
Ofloxacin—TOP2A—Methyltestosterone—Prednisolone—rheumatoid arthritis	0.000254	0.217	CbGdCrCtD
Ofloxacin—TOP2A—Norethindrone—Hydrocortisone—rheumatoid arthritis	0.000197	0.168	CbGdCrCtD
Ofloxacin—TOP2A—Levonorgestrel—Hydrocortisone—rheumatoid arthritis	0.000157	0.134	CbGdCrCtD
Ofloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—RUNX1—rheumatoid arthritis	0.000122	0.0313	CbGpPWpGaD
Ofloxacin—ABCC1—Synthesis of Leukotrienes (LT) and Eoxins (EX)—ALOX5—rheumatoid arthritis	0.000113	0.029	CbGpPWpGaD
Ofloxacin—ABCC1—Arachidonic acid metabolism—PTGES—rheumatoid arthritis	8.98e-05	0.0231	CbGpPWpGaD
Ofloxacin—ABCC2—Drug Induction of Bile Acid Pathway—VDR—rheumatoid arthritis	7.71e-05	0.0198	CbGpPWpGaD
Ofloxacin—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A4—rheumatoid arthritis	7.31e-05	0.0188	CbGpPWpGaD
Ofloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—BDKRB2—rheumatoid arthritis	6.26e-05	0.0161	CbGpPWpGaD
Ofloxacin—SLC22A4—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—rheumatoid arthritis	6.06e-05	0.0156	CbGpPWpGaD
Ofloxacin—ABCC1—Arachidonic acid metabolism—ALOX5—rheumatoid arthritis	5.64e-05	0.0145	CbGpPWpGaD
Ofloxacin—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A4—rheumatoid arthritis	5.52e-05	0.0142	CbGpPWpGaD
Ofloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—VDR—rheumatoid arthritis	4.88e-05	0.0125	CbGpPWpGaD
Ofloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—IL1A—rheumatoid arthritis	4.77e-05	0.0123	CbGpPWpGaD
Ofloxacin—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—rheumatoid arthritis	4.56e-05	0.0117	CbGpPWpGaD
Ofloxacin—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—rheumatoid arthritis	4.43e-05	0.0114	CbGpPWpGaD
Ofloxacin—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—ACP5—rheumatoid arthritis	4.37e-05	0.0112	CbGpPWpGaD
Ofloxacin—Decreased appetite—Hydrocortisone—rheumatoid arthritis	4.29e-05	0.000222	CcSEcCtD
Ofloxacin—Pharyngitis—Methotrexate—rheumatoid arthritis	4.28e-05	0.000222	CcSEcCtD
Ofloxacin—Nausea—Leflunomide—rheumatoid arthritis	4.27e-05	0.000221	CcSEcCtD
Ofloxacin—Urinary tract disorder—Methotrexate—rheumatoid arthritis	4.26e-05	0.00022	CcSEcCtD
Ofloxacin—Gastrointestinal disorder—Hydrocortisone—rheumatoid arthritis	4.26e-05	0.00022	CcSEcCtD
Ofloxacin—Fatigue—Hydrocortisone—rheumatoid arthritis	4.25e-05	0.00022	CcSEcCtD
Ofloxacin—Vision blurred—Prednisone—rheumatoid arthritis	4.24e-05	0.000219	CcSEcCtD
Ofloxacin—Urethral disorder—Methotrexate—rheumatoid arthritis	4.23e-05	0.000219	CcSEcCtD
Ofloxacin—Musculoskeletal discomfort—Triamcinolone—rheumatoid arthritis	4.23e-05	0.000219	CcSEcCtD
Ofloxacin—Musculoskeletal discomfort—Methylprednisolone—rheumatoid arthritis	4.22e-05	0.000218	CcSEcCtD
Ofloxacin—Pain—Hydrocortisone—rheumatoid arthritis	4.22e-05	0.000218	CcSEcCtD
Ofloxacin—Oedema—Dexamethasone—rheumatoid arthritis	4.21e-05	0.000218	CcSEcCtD
Ofloxacin—Oedema—Betamethasone—rheumatoid arthritis	4.21e-05	0.000218	CcSEcCtD
Ofloxacin—Anaphylactic shock—Betamethasone—rheumatoid arthritis	4.21e-05	0.000218	CcSEcCtD
Ofloxacin—Anaphylactic shock—Dexamethasone—rheumatoid arthritis	4.21e-05	0.000218	CcSEcCtD
Ofloxacin—Insomnia—Triamcinolone—rheumatoid arthritis	4.2e-05	0.000217	CcSEcCtD
Ofloxacin—Insomnia—Methylprednisolone—rheumatoid arthritis	4.19e-05	0.000217	CcSEcCtD
Ofloxacin—Infection—Dexamethasone—rheumatoid arthritis	4.19e-05	0.000216	CcSEcCtD
Ofloxacin—Infection—Betamethasone—rheumatoid arthritis	4.19e-05	0.000216	CcSEcCtD
Ofloxacin—Ill-defined disorder—Prednisone—rheumatoid arthritis	4.17e-05	0.000216	CcSEcCtD
Ofloxacin—Paraesthesia—Triamcinolone—rheumatoid arthritis	4.17e-05	0.000216	CcSEcCtD
Ofloxacin—Feeling abnormal—Prednisolone—rheumatoid arthritis	4.16e-05	0.000215	CcSEcCtD
Ofloxacin—Paraesthesia—Methylprednisolone—rheumatoid arthritis	4.16e-05	0.000215	CcSEcCtD
Ofloxacin—Visual impairment—Methotrexate—rheumatoid arthritis	4.16e-05	0.000215	CcSEcCtD
Ofloxacin—Anaemia—Prednisone—rheumatoid arthritis	4.15e-05	0.000215	CcSEcCtD
Ofloxacin—Shock—Betamethasone—rheumatoid arthritis	4.14e-05	0.000214	CcSEcCtD
Ofloxacin—Shock—Dexamethasone—rheumatoid arthritis	4.14e-05	0.000214	CcSEcCtD
Ofloxacin—Dyspnoea—Triamcinolone—rheumatoid arthritis	4.14e-05	0.000214	CcSEcCtD
Ofloxacin—Nervous system disorder—Betamethasone—rheumatoid arthritis	4.13e-05	0.000214	CcSEcCtD
Ofloxacin—Nervous system disorder—Dexamethasone—rheumatoid arthritis	4.13e-05	0.000214	CcSEcCtD
Ofloxacin—Agitation—Prednisone—rheumatoid arthritis	4.13e-05	0.000214	CcSEcCtD
Ofloxacin—Thrombocytopenia—Dexamethasone—rheumatoid arthritis	4.12e-05	0.000213	CcSEcCtD
Ofloxacin—Thrombocytopenia—Betamethasone—rheumatoid arthritis	4.12e-05	0.000213	CcSEcCtD
Ofloxacin—Tachycardia—Dexamethasone—rheumatoid arthritis	4.11e-05	0.000213	CcSEcCtD
Ofloxacin—Tachycardia—Betamethasone—rheumatoid arthritis	4.11e-05	0.000213	CcSEcCtD
Ofloxacin—Angioedema—Prednisone—rheumatoid arthritis	4.11e-05	0.000212	CcSEcCtD
Ofloxacin—Hypersensitivity—Cyclosporine—rheumatoid arthritis	4.09e-05	0.000211	CcSEcCtD
Ofloxacin—Dyspepsia—Triamcinolone—rheumatoid arthritis	4.09e-05	0.000211	CcSEcCtD
Ofloxacin—Erythema multiforme—Methotrexate—rheumatoid arthritis	4.08e-05	0.000211	CcSEcCtD
Ofloxacin—Dyspepsia—Methylprednisolone—rheumatoid arthritis	4.08e-05	0.000211	CcSEcCtD
Ofloxacin—Hyperhidrosis—Betamethasone—rheumatoid arthritis	4.07e-05	0.000211	CcSEcCtD
Ofloxacin—Hyperhidrosis—Dexamethasone—rheumatoid arthritis	4.07e-05	0.000211	CcSEcCtD
Ofloxacin—Feeling abnormal—Hydrocortisone—rheumatoid arthritis	4.06e-05	0.00021	CcSEcCtD
Ofloxacin—Malaise—Prednisone—rheumatoid arthritis	4.05e-05	0.00021	CcSEcCtD
Ofloxacin—Vertigo—Prednisone—rheumatoid arthritis	4.04e-05	0.000209	CcSEcCtD
Ofloxacin—Eye disorder—Methotrexate—rheumatoid arthritis	4.03e-05	0.000209	CcSEcCtD
Ofloxacin—Gastrointestinal pain—Hydrocortisone—rheumatoid arthritis	4.03e-05	0.000209	CcSEcCtD
Ofloxacin—Syncope—Prednisone—rheumatoid arthritis	4.03e-05	0.000208	CcSEcCtD
Ofloxacin—Tinnitus—Methotrexate—rheumatoid arthritis	4.02e-05	0.000208	CcSEcCtD
Ofloxacin—Anorexia—Dexamethasone—rheumatoid arthritis	4.02e-05	0.000208	CcSEcCtD
Ofloxacin—Anorexia—Betamethasone—rheumatoid arthritis	4.02e-05	0.000208	CcSEcCtD
Ofloxacin—Urticaria—Prednisolone—rheumatoid arthritis	4.01e-05	0.000207	CcSEcCtD
Ofloxacin—Cardiac disorder—Methotrexate—rheumatoid arthritis	4.01e-05	0.000207	CcSEcCtD
Ofloxacin—Fatigue—Triamcinolone—rheumatoid arthritis	4e-05	0.000207	CcSEcCtD
Ofloxacin—Fatigue—Methylprednisolone—rheumatoid arthritis	3.99e-05	0.000207	CcSEcCtD
Ofloxacin—Asthenia—Cyclosporine—rheumatoid arthritis	3.98e-05	0.000206	CcSEcCtD
Ofloxacin—Pain—Triamcinolone—rheumatoid arthritis	3.97e-05	0.000205	CcSEcCtD
Ofloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CDK6—rheumatoid arthritis	3.96e-05	0.0102	CbGpPWpGaD
Ofloxacin—Loss of consciousness—Prednisone—rheumatoid arthritis	3.95e-05	0.000204	CcSEcCtD
Ofloxacin—Hypotension—Betamethasone—rheumatoid arthritis	3.94e-05	0.000204	CcSEcCtD
Ofloxacin—Hypotension—Dexamethasone—rheumatoid arthritis	3.94e-05	0.000204	CcSEcCtD
Ofloxacin—Pruritus—Cyclosporine—rheumatoid arthritis	3.93e-05	0.000203	CcSEcCtD
Ofloxacin—Urticaria—Hydrocortisone—rheumatoid arthritis	3.92e-05	0.000203	CcSEcCtD
Ofloxacin—Angiopathy—Methotrexate—rheumatoid arthritis	3.92e-05	0.000202	CcSEcCtD
Ofloxacin—Immune system disorder—Methotrexate—rheumatoid arthritis	3.9e-05	0.000202	CcSEcCtD
Ofloxacin—Body temperature increased—Hydrocortisone—rheumatoid arthritis	3.9e-05	0.000202	CcSEcCtD
Ofloxacin—Abdominal pain—Hydrocortisone—rheumatoid arthritis	3.9e-05	0.000202	CcSEcCtD
Ofloxacin—Mediastinal disorder—Methotrexate—rheumatoid arthritis	3.89e-05	0.000201	CcSEcCtD
Ofloxacin—Hypertension—Prednisone—rheumatoid arthritis	3.88e-05	0.000201	CcSEcCtD
Ofloxacin—Chills—Methotrexate—rheumatoid arthritis	3.87e-05	0.0002	CcSEcCtD
Ofloxacin—Musculoskeletal discomfort—Dexamethasone—rheumatoid arthritis	3.84e-05	0.000198	CcSEcCtD
Ofloxacin—Musculoskeletal discomfort—Betamethasone—rheumatoid arthritis	3.84e-05	0.000198	CcSEcCtD
Ofloxacin—Arthralgia—Prednisone—rheumatoid arthritis	3.83e-05	0.000198	CcSEcCtD
Ofloxacin—Myalgia—Prednisone—rheumatoid arthritis	3.83e-05	0.000198	CcSEcCtD
Ofloxacin—Feeling abnormal—Triamcinolone—rheumatoid arthritis	3.83e-05	0.000198	CcSEcCtD
Ofloxacin—ABCC1—S1P1 pathway—PTGS2—rheumatoid arthritis	3.82e-05	0.00983	CbGpPWpGaD
Ofloxacin—Feeling abnormal—Methylprednisolone—rheumatoid arthritis	3.82e-05	0.000197	CcSEcCtD
Ofloxacin—Anxiety—Prednisone—rheumatoid arthritis	3.81e-05	0.000197	CcSEcCtD
Ofloxacin—Alopecia—Methotrexate—rheumatoid arthritis	3.81e-05	0.000197	CcSEcCtD
Ofloxacin—Insomnia—Dexamethasone—rheumatoid arthritis	3.81e-05	0.000197	CcSEcCtD
Ofloxacin—Insomnia—Betamethasone—rheumatoid arthritis	3.81e-05	0.000197	CcSEcCtD
Ofloxacin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—rheumatoid arthritis	3.8e-05	0.000197	CcSEcCtD
Ofloxacin—Diarrhoea—Cyclosporine—rheumatoid arthritis	3.8e-05	0.000196	CcSEcCtD
Ofloxacin—Gastrointestinal pain—Methylprednisolone—rheumatoid arthritis	3.79e-05	0.000196	CcSEcCtD
Ofloxacin—Paraesthesia—Dexamethasone—rheumatoid arthritis	3.78e-05	0.000196	CcSEcCtD
Ofloxacin—Paraesthesia—Betamethasone—rheumatoid arthritis	3.78e-05	0.000196	CcSEcCtD
Ofloxacin—Discomfort—Prednisone—rheumatoid arthritis	3.78e-05	0.000196	CcSEcCtD
Ofloxacin—Mental disorder—Methotrexate—rheumatoid arthritis	3.78e-05	0.000196	CcSEcCtD
Ofloxacin—Erythema—Methotrexate—rheumatoid arthritis	3.76e-05	0.000194	CcSEcCtD
Ofloxacin—Malnutrition—Methotrexate—rheumatoid arthritis	3.76e-05	0.000194	CcSEcCtD
Ofloxacin—TOP2A—Retinoblastoma (RB) in Cancer—HMGB1—rheumatoid arthritis	3.73e-05	0.00959	CbGpPWpGaD
Ofloxacin—Hypersensitivity—Prednisolone—rheumatoid arthritis	3.72e-05	0.000192	CcSEcCtD
Ofloxacin—Dyspepsia—Dexamethasone—rheumatoid arthritis	3.71e-05	0.000192	CcSEcCtD
Ofloxacin—Dyspepsia—Betamethasone—rheumatoid arthritis	3.71e-05	0.000192	CcSEcCtD
Ofloxacin—Urticaria—Triamcinolone—rheumatoid arthritis	3.69e-05	0.000191	CcSEcCtD
Ofloxacin—Urticaria—Methylprednisolone—rheumatoid arthritis	3.68e-05	0.00019	CcSEcCtD
Ofloxacin—Dysgeusia—Methotrexate—rheumatoid arthritis	3.68e-05	0.00019	CcSEcCtD
Ofloxacin—Body temperature increased—Triamcinolone—rheumatoid arthritis	3.67e-05	0.00019	CcSEcCtD
Ofloxacin—Dizziness—Cyclosporine—rheumatoid arthritis	3.67e-05	0.00019	CcSEcCtD
Ofloxacin—Oedema—Prednisone—rheumatoid arthritis	3.67e-05	0.00019	CcSEcCtD
Ofloxacin—Anaphylactic shock—Prednisone—rheumatoid arthritis	3.67e-05	0.00019	CcSEcCtD
Ofloxacin—Abdominal pain—Methylprednisolone—rheumatoid arthritis	3.66e-05	0.000189	CcSEcCtD
Ofloxacin—Decreased appetite—Betamethasone—rheumatoid arthritis	3.66e-05	0.000189	CcSEcCtD
Ofloxacin—Decreased appetite—Dexamethasone—rheumatoid arthritis	3.66e-05	0.000189	CcSEcCtD
Ofloxacin—Infection—Prednisone—rheumatoid arthritis	3.64e-05	0.000188	CcSEcCtD
Ofloxacin—Gastrointestinal disorder—Betamethasone—rheumatoid arthritis	3.64e-05	0.000188	CcSEcCtD
Ofloxacin—Gastrointestinal disorder—Dexamethasone—rheumatoid arthritis	3.64e-05	0.000188	CcSEcCtD
Ofloxacin—Back pain—Methotrexate—rheumatoid arthritis	3.63e-05	0.000188	CcSEcCtD
Ofloxacin—Hypersensitivity—Hydrocortisone—rheumatoid arthritis	3.63e-05	0.000188	CcSEcCtD
Ofloxacin—Fatigue—Dexamethasone—rheumatoid arthritis	3.63e-05	0.000188	CcSEcCtD
Ofloxacin—Fatigue—Betamethasone—rheumatoid arthritis	3.63e-05	0.000188	CcSEcCtD
Ofloxacin—Shock—Prednisone—rheumatoid arthritis	3.61e-05	0.000187	CcSEcCtD
Ofloxacin—Pain—Betamethasone—rheumatoid arthritis	3.6e-05	0.000186	CcSEcCtD
Ofloxacin—Pain—Dexamethasone—rheumatoid arthritis	3.6e-05	0.000186	CcSEcCtD
Ofloxacin—Nervous system disorder—Prednisone—rheumatoid arthritis	3.6e-05	0.000186	CcSEcCtD
Ofloxacin—Tachycardia—Prednisone—rheumatoid arthritis	3.58e-05	0.000185	CcSEcCtD
Ofloxacin—Skin disorder—Prednisone—rheumatoid arthritis	3.56e-05	0.000184	CcSEcCtD
Ofloxacin—Hyperhidrosis—Prednisone—rheumatoid arthritis	3.55e-05	0.000183	CcSEcCtD
Ofloxacin—Vision blurred—Methotrexate—rheumatoid arthritis	3.54e-05	0.000183	CcSEcCtD
Ofloxacin—Asthenia—Hydrocortisone—rheumatoid arthritis	3.54e-05	0.000183	CcSEcCtD
Ofloxacin—Vomiting—Cyclosporine—rheumatoid arthritis	3.53e-05	0.000182	CcSEcCtD
Ofloxacin—Rash—Cyclosporine—rheumatoid arthritis	3.5e-05	0.000181	CcSEcCtD
Ofloxacin—Anorexia—Prednisone—rheumatoid arthritis	3.5e-05	0.000181	CcSEcCtD
Ofloxacin—Dermatitis—Cyclosporine—rheumatoid arthritis	3.5e-05	0.000181	CcSEcCtD
Ofloxacin—Pruritus—Hydrocortisone—rheumatoid arthritis	3.49e-05	0.00018	CcSEcCtD
Ofloxacin—Ill-defined disorder—Methotrexate—rheumatoid arthritis	3.49e-05	0.00018	CcSEcCtD
Ofloxacin—Headache—Cyclosporine—rheumatoid arthritis	3.48e-05	0.00018	CcSEcCtD
Ofloxacin—Anaemia—Methotrexate—rheumatoid arthritis	3.47e-05	0.00018	CcSEcCtD
Ofloxacin—Feeling abnormal—Betamethasone—rheumatoid arthritis	3.47e-05	0.00018	CcSEcCtD
Ofloxacin—Feeling abnormal—Dexamethasone—rheumatoid arthritis	3.47e-05	0.00018	CcSEcCtD
Ofloxacin—Gastrointestinal pain—Betamethasone—rheumatoid arthritis	3.44e-05	0.000178	CcSEcCtD
Ofloxacin—Gastrointestinal pain—Dexamethasone—rheumatoid arthritis	3.44e-05	0.000178	CcSEcCtD
Ofloxacin—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—rheumatoid arthritis	3.44e-05	0.00885	CbGpPWpGaD
Ofloxacin—Hypersensitivity—Triamcinolone—rheumatoid arthritis	3.42e-05	0.000177	CcSEcCtD
Ofloxacin—Hypersensitivity—Methylprednisolone—rheumatoid arthritis	3.41e-05	0.000177	CcSEcCtD
Ofloxacin—CYP1A2—Arachidonic acid metabolism—PTGES—rheumatoid arthritis	3.41e-05	0.00878	CbGpPWpGaD
Ofloxacin—Malaise—Methotrexate—rheumatoid arthritis	3.39e-05	0.000175	CcSEcCtD
Ofloxacin—Vertigo—Methotrexate—rheumatoid arthritis	3.38e-05	0.000175	CcSEcCtD
Ofloxacin—Diarrhoea—Hydrocortisone—rheumatoid arthritis	3.37e-05	0.000174	CcSEcCtD
Ofloxacin—Leukopenia—Methotrexate—rheumatoid arthritis	3.36e-05	0.000174	CcSEcCtD
Ofloxacin—Urticaria—Betamethasone—rheumatoid arthritis	3.35e-05	0.000173	CcSEcCtD
Ofloxacin—Urticaria—Dexamethasone—rheumatoid arthritis	3.35e-05	0.000173	CcSEcCtD
Ofloxacin—Musculoskeletal discomfort—Prednisone—rheumatoid arthritis	3.34e-05	0.000173	CcSEcCtD
Ofloxacin—Dizziness—Prednisolone—rheumatoid arthritis	3.34e-05	0.000173	CcSEcCtD
Ofloxacin—Asthenia—Triamcinolone—rheumatoid arthritis	3.33e-05	0.000172	CcSEcCtD
Ofloxacin—Body temperature increased—Dexamethasone—rheumatoid arthritis	3.33e-05	0.000172	CcSEcCtD
Ofloxacin—Abdominal pain—Dexamethasone—rheumatoid arthritis	3.33e-05	0.000172	CcSEcCtD
Ofloxacin—Abdominal pain—Betamethasone—rheumatoid arthritis	3.33e-05	0.000172	CcSEcCtD
Ofloxacin—Body temperature increased—Betamethasone—rheumatoid arthritis	3.33e-05	0.000172	CcSEcCtD
Ofloxacin—SLC22A5—SLC-mediated transmembrane transport—SLC22A4—rheumatoid arthritis	3.32e-05	0.00855	CbGpPWpGaD
Ofloxacin—Asthenia—Methylprednisolone—rheumatoid arthritis	3.32e-05	0.000172	CcSEcCtD
Ofloxacin—Insomnia—Prednisone—rheumatoid arthritis	3.32e-05	0.000172	CcSEcCtD
Ofloxacin—Nausea—Cyclosporine—rheumatoid arthritis	3.3e-05	0.00017	CcSEcCtD
Ofloxacin—Paraesthesia—Prednisone—rheumatoid arthritis	3.29e-05	0.00017	CcSEcCtD
Ofloxacin—Pruritus—Triamcinolone—rheumatoid arthritis	3.28e-05	0.00017	CcSEcCtD
Ofloxacin—Cough—Methotrexate—rheumatoid arthritis	3.28e-05	0.00017	CcSEcCtD
Ofloxacin—Pruritus—Methylprednisolone—rheumatoid arthritis	3.28e-05	0.000169	CcSEcCtD
Ofloxacin—Dizziness—Hydrocortisone—rheumatoid arthritis	3.26e-05	0.000169	CcSEcCtD
Ofloxacin—SLC22A4—Transmembrane transport of small molecules—LCN2—rheumatoid arthritis	3.24e-05	0.00834	CbGpPWpGaD
Ofloxacin—Dyspepsia—Prednisone—rheumatoid arthritis	3.23e-05	0.000167	CcSEcCtD
Ofloxacin—Chest pain—Methotrexate—rheumatoid arthritis	3.2e-05	0.000165	CcSEcCtD
Ofloxacin—Myalgia—Methotrexate—rheumatoid arthritis	3.2e-05	0.000165	CcSEcCtD
Ofloxacin—Arthralgia—Methotrexate—rheumatoid arthritis	3.2e-05	0.000165	CcSEcCtD
Ofloxacin—Decreased appetite—Prednisone—rheumatoid arthritis	3.19e-05	0.000165	CcSEcCtD
Ofloxacin—Rash—Prednisolone—rheumatoid arthritis	3.18e-05	0.000165	CcSEcCtD
Ofloxacin—Dermatitis—Prednisolone—rheumatoid arthritis	3.18e-05	0.000164	CcSEcCtD
Ofloxacin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—rheumatoid arthritis	3.18e-05	0.000164	CcSEcCtD
Ofloxacin—Diarrhoea—Methylprednisolone—rheumatoid arthritis	3.17e-05	0.000164	CcSEcCtD
Ofloxacin—Fatigue—Prednisone—rheumatoid arthritis	3.16e-05	0.000164	CcSEcCtD
Ofloxacin—Headache—Prednisolone—rheumatoid arthritis	3.16e-05	0.000164	CcSEcCtD
Ofloxacin—Discomfort—Methotrexate—rheumatoid arthritis	3.16e-05	0.000163	CcSEcCtD
Ofloxacin—Constipation—Prednisone—rheumatoid arthritis	3.14e-05	0.000162	CcSEcCtD
Ofloxacin—Vomiting—Hydrocortisone—rheumatoid arthritis	3.14e-05	0.000162	CcSEcCtD
Ofloxacin—Rash—Hydrocortisone—rheumatoid arthritis	3.11e-05	0.000161	CcSEcCtD
Ofloxacin—Dermatitis—Hydrocortisone—rheumatoid arthritis	3.11e-05	0.000161	CcSEcCtD
Ofloxacin—Confusional state—Methotrexate—rheumatoid arthritis	3.09e-05	0.00016	CcSEcCtD
Ofloxacin—Headache—Hydrocortisone—rheumatoid arthritis	3.09e-05	0.00016	CcSEcCtD
Ofloxacin—Dizziness—Triamcinolone—rheumatoid arthritis	3.07e-05	0.000159	CcSEcCtD
Ofloxacin—Anaphylactic shock—Methotrexate—rheumatoid arthritis	3.07e-05	0.000159	CcSEcCtD
Ofloxacin—Dizziness—Methylprednisolone—rheumatoid arthritis	3.06e-05	0.000158	CcSEcCtD
Ofloxacin—Infection—Methotrexate—rheumatoid arthritis	3.05e-05	0.000158	CcSEcCtD
Ofloxacin—Feeling abnormal—Prednisone—rheumatoid arthritis	3.02e-05	0.000156	CcSEcCtD
Ofloxacin—Asthenia—Dexamethasone—rheumatoid arthritis	3.02e-05	0.000156	CcSEcCtD
Ofloxacin—Asthenia—Betamethasone—rheumatoid arthritis	3.02e-05	0.000156	CcSEcCtD
Ofloxacin—ABCC1—S1P1 pathway—VEGFA—rheumatoid arthritis	3.01e-05	0.00774	CbGpPWpGaD
Ofloxacin—Nervous system disorder—Methotrexate—rheumatoid arthritis	3.01e-05	0.000156	CcSEcCtD
Ofloxacin—Thrombocytopenia—Methotrexate—rheumatoid arthritis	3e-05	0.000155	CcSEcCtD
Ofloxacin—Gastrointestinal pain—Prednisone—rheumatoid arthritis	3e-05	0.000155	CcSEcCtD
Ofloxacin—Nausea—Prednisolone—rheumatoid arthritis	3e-05	0.000155	CcSEcCtD
Ofloxacin—Pruritus—Betamethasone—rheumatoid arthritis	2.98e-05	0.000154	CcSEcCtD
Ofloxacin—Pruritus—Dexamethasone—rheumatoid arthritis	2.98e-05	0.000154	CcSEcCtD
Ofloxacin—Skin disorder—Methotrexate—rheumatoid arthritis	2.98e-05	0.000154	CcSEcCtD
Ofloxacin—Hyperhidrosis—Methotrexate—rheumatoid arthritis	2.96e-05	0.000153	CcSEcCtD
Ofloxacin—Vomiting—Triamcinolone—rheumatoid arthritis	2.95e-05	0.000153	CcSEcCtD
Ofloxacin—Vomiting—Methylprednisolone—rheumatoid arthritis	2.95e-05	0.000152	CcSEcCtD
Ofloxacin—Nausea—Hydrocortisone—rheumatoid arthritis	2.93e-05	0.000151	CcSEcCtD
Ofloxacin—Rash—Triamcinolone—rheumatoid arthritis	2.93e-05	0.000151	CcSEcCtD
Ofloxacin—Dermatitis—Triamcinolone—rheumatoid arthritis	2.92e-05	0.000151	CcSEcCtD
Ofloxacin—Anorexia—Methotrexate—rheumatoid arthritis	2.92e-05	0.000151	CcSEcCtD
Ofloxacin—Rash—Methylprednisolone—rheumatoid arthritis	2.92e-05	0.000151	CcSEcCtD
Ofloxacin—Dermatitis—Methylprednisolone—rheumatoid arthritis	2.92e-05	0.000151	CcSEcCtD
Ofloxacin—TOP2A—Cell Cycle, Mitotic—CEP57—rheumatoid arthritis	2.92e-05	0.0075	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle, Mitotic—CDK5RAP2—rheumatoid arthritis	2.92e-05	0.0075	CbGpPWpGaD
Ofloxacin—Urticaria—Prednisone—rheumatoid arthritis	2.91e-05	0.000151	CcSEcCtD
Ofloxacin—Headache—Triamcinolone—rheumatoid arthritis	2.91e-05	0.00015	CcSEcCtD
Ofloxacin—Headache—Methylprednisolone—rheumatoid arthritis	2.9e-05	0.00015	CcSEcCtD
Ofloxacin—Abdominal pain—Prednisone—rheumatoid arthritis	2.9e-05	0.00015	CcSEcCtD
Ofloxacin—Body temperature increased—Prednisone—rheumatoid arthritis	2.9e-05	0.00015	CcSEcCtD
Ofloxacin—Diarrhoea—Dexamethasone—rheumatoid arthritis	2.88e-05	0.000149	CcSEcCtD
Ofloxacin—Diarrhoea—Betamethasone—rheumatoid arthritis	2.88e-05	0.000149	CcSEcCtD
Ofloxacin—Hypotension—Methotrexate—rheumatoid arthritis	2.87e-05	0.000148	CcSEcCtD
Ofloxacin—Musculoskeletal discomfort—Methotrexate—rheumatoid arthritis	2.79e-05	0.000144	CcSEcCtD
Ofloxacin—TOP2A—Mitotic G1-G1/S phases—CDK6—rheumatoid arthritis	2.79e-05	0.00718	CbGpPWpGaD
Ofloxacin—Dizziness—Betamethasone—rheumatoid arthritis	2.79e-05	0.000144	CcSEcCtD
Ofloxacin—Dizziness—Dexamethasone—rheumatoid arthritis	2.79e-05	0.000144	CcSEcCtD
Ofloxacin—Insomnia—Methotrexate—rheumatoid arthritis	2.77e-05	0.000143	CcSEcCtD
Ofloxacin—Nausea—Triamcinolone—rheumatoid arthritis	2.76e-05	0.000143	CcSEcCtD
Ofloxacin—SLC22A4—SLC-mediated transmembrane transport—SLC11A1—rheumatoid arthritis	2.75e-05	0.00709	CbGpPWpGaD
Ofloxacin—Paraesthesia—Methotrexate—rheumatoid arthritis	2.75e-05	0.000142	CcSEcCtD
Ofloxacin—Nausea—Methylprednisolone—rheumatoid arthritis	2.75e-05	0.000142	CcSEcCtD
Ofloxacin—TOP2A—Circadian rythm related genes—AHR—rheumatoid arthritis	2.75e-05	0.00707	CbGpPWpGaD
Ofloxacin—Dyspnoea—Methotrexate—rheumatoid arthritis	2.73e-05	0.000141	CcSEcCtD
Ofloxacin—Somnolence—Methotrexate—rheumatoid arthritis	2.73e-05	0.000141	CcSEcCtD
Ofloxacin—Hypersensitivity—Prednisone—rheumatoid arthritis	2.7e-05	0.00014	CcSEcCtD
Ofloxacin—Dyspepsia—Methotrexate—rheumatoid arthritis	2.7e-05	0.00014	CcSEcCtD
Ofloxacin—Vomiting—Dexamethasone—rheumatoid arthritis	2.68e-05	0.000139	CcSEcCtD
Ofloxacin—Vomiting—Betamethasone—rheumatoid arthritis	2.68e-05	0.000139	CcSEcCtD
Ofloxacin—Decreased appetite—Methotrexate—rheumatoid arthritis	2.67e-05	0.000138	CcSEcCtD
Ofloxacin—Rash—Dexamethasone—rheumatoid arthritis	2.66e-05	0.000137	CcSEcCtD
Ofloxacin—Rash—Betamethasone—rheumatoid arthritis	2.66e-05	0.000137	CcSEcCtD
Ofloxacin—Dermatitis—Dexamethasone—rheumatoid arthritis	2.65e-05	0.000137	CcSEcCtD
Ofloxacin—Dermatitis—Betamethasone—rheumatoid arthritis	2.65e-05	0.000137	CcSEcCtD
Ofloxacin—Gastrointestinal disorder—Methotrexate—rheumatoid arthritis	2.65e-05	0.000137	CcSEcCtD
Ofloxacin—Fatigue—Methotrexate—rheumatoid arthritis	2.64e-05	0.000137	CcSEcCtD
Ofloxacin—Headache—Dexamethasone—rheumatoid arthritis	2.64e-05	0.000136	CcSEcCtD
Ofloxacin—Headache—Betamethasone—rheumatoid arthritis	2.64e-05	0.000136	CcSEcCtD
Ofloxacin—Asthenia—Prednisone—rheumatoid arthritis	2.63e-05	0.000136	CcSEcCtD
Ofloxacin—Pain—Methotrexate—rheumatoid arthritis	2.62e-05	0.000136	CcSEcCtD
Ofloxacin—TOP2A—Cell Cycle—CDK5RAP2—rheumatoid arthritis	2.61e-05	0.00671	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle—CEP57—rheumatoid arthritis	2.61e-05	0.00671	CbGpPWpGaD
Ofloxacin—Pruritus—Prednisone—rheumatoid arthritis	2.6e-05	0.000134	CcSEcCtD
Ofloxacin—Feeling abnormal—Methotrexate—rheumatoid arthritis	2.53e-05	0.000131	CcSEcCtD
Ofloxacin—Diarrhoea—Prednisone—rheumatoid arthritis	2.51e-05	0.00013	CcSEcCtD
Ofloxacin—SLC22A6—SLC-mediated transmembrane transport—SLC22A4—rheumatoid arthritis	2.51e-05	0.00645	CbGpPWpGaD
Ofloxacin—Gastrointestinal pain—Methotrexate—rheumatoid arthritis	2.51e-05	0.00013	CcSEcCtD
Ofloxacin—Nausea—Dexamethasone—rheumatoid arthritis	2.5e-05	0.000129	CcSEcCtD
Ofloxacin—Nausea—Betamethasone—rheumatoid arthritis	2.5e-05	0.000129	CcSEcCtD
Ofloxacin—SLC22A5—Transmembrane transport of small molecules—LCN2—rheumatoid arthritis	2.44e-05	0.00627	CbGpPWpGaD
Ofloxacin—Urticaria—Methotrexate—rheumatoid arthritis	2.44e-05	0.000126	CcSEcCtD
Ofloxacin—Dizziness—Prednisone—rheumatoid arthritis	2.43e-05	0.000125	CcSEcCtD
Ofloxacin—Abdominal pain—Methotrexate—rheumatoid arthritis	2.42e-05	0.000125	CcSEcCtD
Ofloxacin—Body temperature increased—Methotrexate—rheumatoid arthritis	2.42e-05	0.000125	CcSEcCtD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—AHR—rheumatoid arthritis	2.35e-05	0.00605	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—AHR—rheumatoid arthritis	2.35e-05	0.00605	CbGpPWpGaD
Ofloxacin—Vomiting—Prednisone—rheumatoid arthritis	2.33e-05	0.000121	CcSEcCtD
Ofloxacin—Rash—Prednisone—rheumatoid arthritis	2.31e-05	0.00012	CcSEcCtD
Ofloxacin—Dermatitis—Prednisone—rheumatoid arthritis	2.31e-05	0.00012	CcSEcCtD
Ofloxacin—Headache—Prednisone—rheumatoid arthritis	2.3e-05	0.000119	CcSEcCtD
Ofloxacin—Hypersensitivity—Methotrexate—rheumatoid arthritis	2.26e-05	0.000117	CcSEcCtD
Ofloxacin—TOP2A—Gastric Cancer Network 2—TP53—rheumatoid arthritis	2.22e-05	0.00571	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle, Mitotic—RAB8A—rheumatoid arthritis	2.21e-05	0.00569	CbGpPWpGaD
Ofloxacin—Asthenia—Methotrexate—rheumatoid arthritis	2.2e-05	0.000114	CcSEcCtD
Ofloxacin—Nausea—Prednisone—rheumatoid arthritis	2.18e-05	0.000113	CcSEcCtD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—FADS2—rheumatoid arthritis	2.18e-05	0.0056	CbGpPWpGaD
Ofloxacin—Pruritus—Methotrexate—rheumatoid arthritis	2.17e-05	0.000112	CcSEcCtD
Ofloxacin—CYP1A2—Arachidonic acid metabolism—ALOX5—rheumatoid arthritis	2.14e-05	0.00551	CbGpPWpGaD
Ofloxacin—Diarrhoea—Methotrexate—rheumatoid arthritis	2.1e-05	0.000108	CcSEcCtD
Ofloxacin—SLC22A5—SLC-mediated transmembrane transport—SLC11A1—rheumatoid arthritis	2.07e-05	0.00533	CbGpPWpGaD
Ofloxacin—Dizziness—Methotrexate—rheumatoid arthritis	2.03e-05	0.000105	CcSEcCtD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TNFRSF1A—rheumatoid arthritis	2.02e-05	0.00519	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle—RAB8A—rheumatoid arthritis	1.98e-05	0.00508	CbGpPWpGaD
Ofloxacin—TOP2A—Circadian rythm related genes—ADIPOQ—rheumatoid arthritis	1.97e-05	0.00506	CbGpPWpGaD
Ofloxacin—Vomiting—Methotrexate—rheumatoid arthritis	1.95e-05	0.000101	CcSEcCtD
Ofloxacin—Rash—Methotrexate—rheumatoid arthritis	1.93e-05	0.0001	CcSEcCtD
Ofloxacin—Dermatitis—Methotrexate—rheumatoid arthritis	1.93e-05	9.99e-05	CcSEcCtD
Ofloxacin—Headache—Methotrexate—rheumatoid arthritis	1.92e-05	9.93e-05	CcSEcCtD
Ofloxacin—SLC22A6—Transmembrane transport of small molecules—LCN2—rheumatoid arthritis	1.84e-05	0.00473	CbGpPWpGaD
Ofloxacin—SLC22A4—Transmembrane transport of small molecules—MED1—rheumatoid arthritis	1.83e-05	0.00471	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—STAT1—rheumatoid arthritis	1.83e-05	0.0047	CbGpPWpGaD
Ofloxacin—Nausea—Methotrexate—rheumatoid arthritis	1.82e-05	9.42e-05	CcSEcCtD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—LCN2—rheumatoid arthritis	1.78e-05	0.00458	CbGpPWpGaD
Ofloxacin—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—rheumatoid arthritis	1.77e-05	0.00456	CbGpPWpGaD
Ofloxacin—ABCC1—Arachidonic acid metabolism—PTGS2—rheumatoid arthritis	1.76e-05	0.00453	CbGpPWpGaD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—LCN2—rheumatoid arthritis	1.76e-05	0.00453	CbGpPWpGaD
Ofloxacin—SLC22A5—Transmembrane transport of small molecules—SLC22A4—rheumatoid arthritis	1.69e-05	0.00435	CbGpPWpGaD
Ofloxacin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—rheumatoid arthritis	1.66e-05	0.00427	CbGpPWpGaD
Ofloxacin—SLC22A6—SLC-mediated transmembrane transport—SLC11A1—rheumatoid arthritis	1.56e-05	0.00402	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—PLD4—rheumatoid arthritis	1.45e-05	0.00374	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—FASLG—rheumatoid arthritis	1.44e-05	0.0037	CbGpPWpGaD
Ofloxacin—SLC22A4—Transmembrane transport of small molecules—SLC11A1—rheumatoid arthritis	1.4e-05	0.0036	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle, Mitotic—TMPO—rheumatoid arthritis	1.4e-05	0.0036	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—FAS—rheumatoid arthritis	1.39e-05	0.00356	CbGpPWpGaD
Ofloxacin—SLC22A5—Transmembrane transport of small molecules—MED1—rheumatoid arthritis	1.38e-05	0.00354	CbGpPWpGaD
Ofloxacin—CYP1A2—Tryptophan metabolism—CAT—rheumatoid arthritis	1.34e-05	0.00346	CbGpPWpGaD
Ofloxacin—TOP2A—Circadian rythm related genes—FAS—rheumatoid arthritis	1.33e-05	0.00342	CbGpPWpGaD
Ofloxacin—ABCC2—NRF2 pathway—AGER—rheumatoid arthritis	1.29e-05	0.00333	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—PTGES—rheumatoid arthritis	1.28e-05	0.0033	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—GC—rheumatoid arthritis	1.28e-05	0.0033	CbGpPWpGaD
Ofloxacin—SLC22A6—Transmembrane transport of small molecules—SLC22A4—rheumatoid arthritis	1.27e-05	0.00328	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle—TMPO—rheumatoid arthritis	1.25e-05	0.00322	CbGpPWpGaD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—SLC22A4—rheumatoid arthritis	1.23e-05	0.00318	CbGpPWpGaD
Ofloxacin—TOP2A—Circadian rythm related genes—LEP—rheumatoid arthritis	1.22e-05	0.00314	CbGpPWpGaD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—SLC22A4—rheumatoid arthritis	1.22e-05	0.00314	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—PLB1—rheumatoid arthritis	1.19e-05	0.00307	CbGpPWpGaD
Ofloxacin—TOP2A—Circadian rythm related genes—NOS2—rheumatoid arthritis	1.14e-05	0.00293	CbGpPWpGaD
Ofloxacin—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—rheumatoid arthritis	1.13e-05	0.00291	CbGpPWpGaD
Ofloxacin—SLC22A5—Transmembrane transport of small molecules—SLC11A1—rheumatoid arthritis	1.05e-05	0.00271	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—MED1—rheumatoid arthritis	1.05e-05	0.00269	CbGpPWpGaD
Ofloxacin—SLC22A6—Transmembrane transport of small molecules—MED1—rheumatoid arthritis	1.04e-05	0.00267	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle, Mitotic—CDK6—rheumatoid arthritis	1.02e-05	0.00263	CbGpPWpGaD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—MED1—rheumatoid arthritis	1.01e-05	0.00259	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle, Mitotic—UBE2D1—rheumatoid arthritis	1.01e-05	0.00259	CbGpPWpGaD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—MED1—rheumatoid arthritis	9.95e-06	0.00256	CbGpPWpGaD
Ofloxacin—SLC22A4—SLC-mediated transmembrane transport—ALB—rheumatoid arthritis	9.92e-06	0.00255	CbGpPWpGaD
Ofloxacin—TOP2A—Retinoblastoma (RB) in Cancer—TP53—rheumatoid arthritis	9.73e-06	0.0025	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—FADS2—rheumatoid arthritis	9.7e-06	0.0025	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle—CDK6—rheumatoid arthritis	9.15e-06	0.00235	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle—UBE2D1—rheumatoid arthritis	9e-06	0.00232	CbGpPWpGaD
Ofloxacin—CYP1A2—Melatonin metabolism and effects—NFKB1—rheumatoid arthritis	8.98e-06	0.00231	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PTGS2—rheumatoid arthritis	8.71e-06	0.00224	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—SYVN1—rheumatoid arthritis	8.37e-06	0.00215	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—FADS2—rheumatoid arthritis	8.27e-06	0.00213	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—ALOX5—rheumatoid arthritis	8.06e-06	0.00207	CbGpPWpGaD
Ofloxacin—SLC22A6—Transmembrane transport of small molecules—SLC11A1—rheumatoid arthritis	7.94e-06	0.00204	CbGpPWpGaD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—SLC11A1—rheumatoid arthritis	7.69e-06	0.00198	CbGpPWpGaD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—SLC11A1—rheumatoid arthritis	7.6e-06	0.00196	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—NFKB1—rheumatoid arthritis	7.56e-06	0.00195	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—ACAN—rheumatoid arthritis	7.46e-06	0.00192	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—rheumatoid arthritis	7.46e-06	0.00192	CbGpPWpGaD
Ofloxacin—SLC22A5—SLC-mediated transmembrane transport—ALB—rheumatoid arthritis	7.45e-06	0.00192	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK8—rheumatoid arthritis	7.43e-06	0.00191	CbGpPWpGaD
Ofloxacin—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—rheumatoid arthritis	7.25e-06	0.00187	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—rheumatoid arthritis	7.15e-06	0.00184	CbGpPWpGaD
Ofloxacin—TOP2A—Circadian rythm related genes—MAPK8—rheumatoid arthritis	7.14e-06	0.00184	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—SLC25A12—rheumatoid arthritis	7.02e-06	0.00181	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—rheumatoid arthritis	6.86e-06	0.00177	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle, Mitotic—BIRC5—rheumatoid arthritis	6.81e-06	0.00175	CbGpPWpGaD
Ofloxacin—CYP1A2—Arachidonic acid metabolism—PTGS2—rheumatoid arthritis	6.69e-06	0.00172	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—rheumatoid arthritis	6.66e-06	0.00171	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—rheumatoid arthritis	6.63e-06	0.00171	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—PLD4—rheumatoid arthritis	6.47e-06	0.00166	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—PLB1—rheumatoid arthritis	6.35e-06	0.00163	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TGFB1—rheumatoid arthritis	6.3e-06	0.00162	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—ACAN—rheumatoid arthritis	6.25e-06	0.00161	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—rheumatoid arthritis	6.21e-06	0.0016	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle—BIRC5—rheumatoid arthritis	6.09e-06	0.00157	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TNF—rheumatoid arthritis	5.88e-06	0.00151	CbGpPWpGaD
Ofloxacin—CYP1A2—Phase 1 - Functionalization of compounds—POMC—rheumatoid arthritis	5.88e-06	0.00151	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—SLC25A12—rheumatoid arthritis	5.88e-06	0.00151	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—RBPJ—rheumatoid arthritis	5.86e-06	0.00151	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—GC—rheumatoid arthritis	5.72e-06	0.00147	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—PTGES—rheumatoid arthritis	5.72e-06	0.00147	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—rheumatoid arthritis	5.63e-06	0.00145	CbGpPWpGaD
Ofloxacin—SLC22A6—SLC-mediated transmembrane transport—ALB—rheumatoid arthritis	5.63e-06	0.00145	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PLD4—rheumatoid arthritis	5.52e-06	0.00142	CbGpPWpGaD
Ofloxacin—ABCC2—NRF2 pathway—TGFB1—rheumatoid arthritis	5.47e-06	0.00141	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—PLB1—rheumatoid arthritis	5.31e-06	0.00137	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—rheumatoid arthritis	5.19e-06	0.00133	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—ACP5—rheumatoid arthritis	5.17e-06	0.00133	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—B3GNT2—rheumatoid arthritis	5.17e-06	0.00133	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—rheumatoid arthritis	5.17e-06	0.00133	CbGpPWpGaD
Ofloxacin—SLC22A4—Transmembrane transport of small molecules—ALB—rheumatoid arthritis	5.04e-06	0.0013	CbGpPWpGaD
Ofloxacin—TOP2A—Circadian rythm related genes—TP53—rheumatoid arthritis	4.98e-06	0.00128	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—GC—rheumatoid arthritis	4.87e-06	0.00125	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PTGES—rheumatoid arthritis	4.87e-06	0.00125	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—rheumatoid arthritis	4.83e-06	0.00124	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—TNF—rheumatoid arthritis	4.83e-06	0.00124	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—MED1—rheumatoid arthritis	4.66e-06	0.0012	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—TLE3—rheumatoid arthritis	4.66e-06	0.0012	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—BGN—rheumatoid arthritis	4.66e-06	0.0012	CbGpPWpGaD
Ofloxacin—TOP2A—Circadian rythm related genes—IL6—rheumatoid arthritis	4.56e-06	0.00117	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PLB1—rheumatoid arthritis	4.53e-06	0.00117	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—ACP5—rheumatoid arthritis	4.33e-06	0.00111	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—B3GNT2—rheumatoid arthritis	4.33e-06	0.00111	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—SLC11A1—rheumatoid arthritis	4.25e-06	0.00109	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—NFATC1—rheumatoid arthritis	4.22e-06	0.00108	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—MED1—rheumatoid arthritis	3.97e-06	0.00102	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—NCF2—rheumatoid arthritis	3.92e-06	0.00101	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—BGN—rheumatoid arthritis	3.9e-06	0.001	CbGpPWpGaD
Ofloxacin—SLC22A5—Transmembrane transport of small molecules—ALB—rheumatoid arthritis	3.79e-06	0.000974	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—FADS2—rheumatoid arthritis	3.68e-06	0.000948	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—SAA1—rheumatoid arthritis	3.6e-06	0.000927	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—ALOX5—rheumatoid arthritis	3.59e-06	0.000924	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—NCF1—rheumatoid arthritis	3.53e-06	0.000908	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—ENO1—rheumatoid arthritis	3.49e-06	0.000899	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—CD28—rheumatoid arthritis	3.39e-06	0.000873	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—UBE2D1—rheumatoid arthritis	3.2e-06	0.000822	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—POMC—rheumatoid arthritis	3.16e-06	0.000812	CbGpPWpGaD
Ofloxacin—CYP1A2—Biological oxidations—POMC—rheumatoid arthritis	3.12e-06	0.000803	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—ADRBK1—rheumatoid arthritis	3.1e-06	0.000797	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—ALOX5—rheumatoid arthritis	3.06e-06	0.000788	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—ENO1—rheumatoid arthritis	2.93e-06	0.000753	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—ALB—rheumatoid arthritis	2.88e-06	0.000741	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—PRKCQ—rheumatoid arthritis	2.86e-06	0.000736	CbGpPWpGaD
Ofloxacin—SLC22A6—Transmembrane transport of small molecules—ALB—rheumatoid arthritis	2.86e-06	0.000735	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—STAT1—rheumatoid arthritis	2.81e-06	0.000723	CbGpPWpGaD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—ALB—rheumatoid arthritis	2.77e-06	0.000712	CbGpPWpGaD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—ALB—rheumatoid arthritis	2.74e-06	0.000704	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—rheumatoid arthritis	2.52e-06	0.000648	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—PLD4—rheumatoid arthritis	2.46e-06	0.000632	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—ACAN—rheumatoid arthritis	2.37e-06	0.000611	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle—TP53—rheumatoid arthritis	2.24e-06	0.000577	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—SLC25A12—rheumatoid arthritis	2.23e-06	0.000574	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—GC—rheumatoid arthritis	2.17e-06	0.000559	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—PTGES—rheumatoid arthritis	2.17e-06	0.000559	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—CCR5—rheumatoid arthritis	2.15e-06	0.000553	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—CAT—rheumatoid arthritis	2.11e-06	0.000542	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—MTHFR—rheumatoid arthritis	2.1e-06	0.00054	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—HLA-A—rheumatoid arthritis	2.09e-06	0.000539	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—PLB1—rheumatoid arthritis	2.02e-06	0.000519	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—IL6ST—rheumatoid arthritis	1.84e-06	0.000472	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—NOS2—rheumatoid arthritis	1.82e-06	0.000469	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—MED1—rheumatoid arthritis	1.77e-06	0.000455	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—CD80—rheumatoid arthritis	1.77e-06	0.000455	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—MTHFR—rheumatoid arthritis	1.76e-06	0.000452	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—ACP5—rheumatoid arthritis	1.65e-06	0.000423	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—B3GNT2—rheumatoid arthritis	1.65e-06	0.000423	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—IL6R—rheumatoid arthritis	1.64e-06	0.000421	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—TYK2—rheumatoid arthritis	1.49e-06	0.000384	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—BGN—rheumatoid arthritis	1.48e-06	0.000381	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—NOS3—rheumatoid arthritis	1.46e-06	0.000377	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—POMC—rheumatoid arthritis	1.41e-06	0.000362	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—ALOX5—rheumatoid arthritis	1.36e-06	0.000351	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—CD4—rheumatoid arthritis	1.35e-06	0.000347	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—PTGS2—rheumatoid arthritis	1.34e-06	0.000345	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—ALB—rheumatoid arthritis	1.28e-06	0.00033	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—NOS3—rheumatoid arthritis	1.23e-06	0.000315	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—POMC—rheumatoid arthritis	1.2e-06	0.000308	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—PTGS2—rheumatoid arthritis	1.12e-06	0.000289	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—ENO1—rheumatoid arthritis	1.11e-06	0.000286	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—ALB—rheumatoid arthritis	1.09e-06	0.000281	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—TGFB1—rheumatoid arthritis	9.68e-07	0.000249	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—rheumatoid arthritis	9.56e-07	0.000246	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—CAT—rheumatoid arthritis	8e-07	0.000206	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—IL6—rheumatoid arthritis	7.3e-07	0.000188	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—MTHFR—rheumatoid arthritis	6.68e-07	0.000172	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—POMC—rheumatoid arthritis	5.34e-07	0.000137	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—ALB—rheumatoid arthritis	4.87e-07	0.000125	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—NOS3—rheumatoid arthritis	4.66e-07	0.00012	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—PTGS2—rheumatoid arthritis	4.26e-07	0.00011	CbGpPWpGaD
